Sankar Dass Navaneethan MD MS, MPH, FASN
Professor of Medicine and Director of Clinical Research, Section of Nephrology, Baylor College of Medicine
Join to View Full Profile
1 Baylor PlazaHouston, TX 77030
Phone+1 713-798-7847
Fax+1 719-888-1868
Dr. Navaneethan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve UniversityMS, Clinical Research, 2010 - 2012
University of Rochester Medical CenterFellowship, Nephrology, 2006 - 2008- Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 2002 - 2006
- University of South CarolinaMS, Public Health, 2001 - 2002
Madras Medical CollegeClass of 2000
Certifications & Licensure
TX State Medical License 2015 - 2026
OH State Medical License 2008 - 2016
NY State Medical License 2005 - 2008
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (ASNF) American Society of Nephrology
Clinical Trials
- Effects of Intentional Weight Loss Interventions in Chronic Kidney Disease Start of enrollment: 2010 Aug 01
Publications & Presentations
PubMed
- GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary.Ian H de Boer, M Luiza Caramori, Juliana C N Chan, Hiddo J L Heerspink, Kamlesh Khunti
Kidney International. 2025-05-01 - Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular fi...Sankar D Navaneethan, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing
Kidney International. 2025-04-21 - Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation.Carl P Walther, L Parker Gregg, Sankar D Navaneethan
American Journal of Kidney Diseases. 2025-03-05
Journal Articles
- Dialysis Modality and Incident Atrial Fibrillation in Older Patients with ESRDJose J Perez, Medha Airy, Sankar D Navaneethan, Wolfgang C Winkelmayer, American Journal of Kidney Diseases
Lectures
- What Markers Should I Follow in My Hospitalized Heart Failure Patient: The Nephrologists Perspective2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Cardiorenal Syndrome in Heart Failure: Balancing the Needs of the Heart and Kidney2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Press Mentions
Outstanding Kidney Care Professionals to Be Honored at NKF SCM25March 7th, 2025- Houston's Sankar Dass Navaneethan, MD, MS, MPH, Named NKF's Garabed Eknoyan Award WinnerFebruary 24th, 2025
- Pulmonary Hypertension in CKD and Risk of Adverse Events and MortalityJanuary 31st, 2022
- Join now to see all
Professional Memberships
- Fellow
- KDIGOMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
